Dr. Michael Moore, DO
What this data tells you about Dr. Moore
Dr. Michael Moore is an interventional cardiology in Spring Hill, FL, with 20 years in practice. Based on federal Medicare data, Dr. Moore performed 2,585 Medicare services across 1,713 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moore received a total of $25,908 from 23 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moore is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 509 | $91 | $195 |
| Hospital follow-up visit, high complexity | 354 | $94 | $144 |
| Initial hospital admission, high complexity | 242 | $137 | $300 |
| Electrocardiogram (EKG), 12-lead | 156 | $11 | $75 |
| Injection, dipyridamole, per 10 mg | 141 | $3 | $10 |
| Remote pacemaker/defibrillator monitoring, 90 days | 131 | $17 | $55 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 120 | $351 | $900 |
| Echocardiogram, transthoracic | 100 | $145 | $395 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 95 | $27 | $90 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 83 | $19 | $40 |
| Remote pacemaker monitoring, 90 days | 77 | $23 | $55 |
| Programming of dual lead pacemaker system | 63 | $57 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 62 | $44 | $150 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 61 | $325 | $600 |
| Infusion, normal saline solution, 250 cc | 61 | $1 | $5 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 56 | $28 | $99 |
| Regadenoson injection (Lexiscan) for heart stress test | 48 | $42 | $75 |
| Evaluation of implantable heart and blood vessel monitoring system | 45 | $33 | $55 |
| Injection, aminophyllin, up to 250 mg | 44 | $7 | $20 |
| New patient office visit (45-59 min) | 36 | $117 | $310 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 30 | $171 | $633 |
| Coronary stent placement | 22 | $425 | $1,290 |
| Office visit, established patient (20-29 min) | 21 | $56 | $138 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $16 | $37 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $11 | $24 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Moore is a remote & electrophysiology specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 19%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Moore experienced with office visit, established patient (30-39 min)?
Does Dr. Moore receive payments from pharmaceutical companies?
How do Dr. Moore's costs compare to other interventional cardiologys in Spring Hill?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology